Advertisement

Topics

Combination therapy for multiple myeloma approved by FDA

10:30 EDT 20 Jun 2017 | EPM Magazine

Genmab has announced that the FDA has approved the use of DARZALEX (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies.

Original Article: Combination therapy for multiple myeloma approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Combination therapy for multiple myeloma approved by FDA"

Advertisement
Quick Search
Advertisement
Advertisement